-
Most Recent
Search Results
240 results for MER
Gilead’s Cash and the Coronavirus Make GILD Stock Look Cheap
Gilead Sciences rose to prominence with its hepatitis C drug. Now GILD stock is soaring on hopes for a coronavirus treatment.
Focus on iBio’s Tech, Not Its Coronavirus Story
IBIO stock shot up in March on news that it might produce a coronavirus vaccine. However, its at-scale production tech is more interesting.
iBio Stock Is Too Risky
IBIO stock gets attention because of iBio’s foray into treating the coronavirus, but investors who want that exposure should look elsewhere.
Don’t Buy Inovio Stock on Hopes for a Vaccine
Coronavirus hysteria on Wall Street is temporary. When it passes, INO stock could turn into a “look out below” situation.
Bet on INO Stock Beyond Its Promising Covid-19 Vaccine Developments
Inovio just launched its Phase 1 trials of INO-4800 for a vaccine. Should all go according to plan, INO could run to at least $20…
Gilead Sciences Pins Its Hopes on Remdesivir
Clinical trial results for Gilead’s remdesivir should come this month. If it’s effective, GILD stock could explode higher on the news.
Investors Should View IBIO Stock Among Vaccine Wanna-be’s, Not Makers
IBIO stock has been acting like a potential COVID-19 vaccine producer, but it lacks contracts with leading providers and its own work remains at a…
Novavax Is the Ultimate Coronavirus Stock
Novavax has failed at late-stage clinical trials before, but if its COVID-19 vaccine even has 50% efficacy it could open up a huge global opportunity.
4 Big, Safe Dividend Plays for the Long Haul
Dividend ETFs are popular with investors, as they seek better performance than bonds provide. Here are four ETFs for the long haul.
5 Best Vanguard Funds to Buy for Target Date 2030 Retirement
You’re going to need some added oomph if you’ve got roughly 15-20 years before retirement. Here’s a look at some of the best Vanguard funds…
3 Cult-Like Stocks to Buy for Long-Term Gains
There are stocks and then there are cult-like stocks. These three are in the latter category for many reasons including making you money.
Capital Destruction Paves Way for Further Losses
Once in a lifetime events are piling up so fast that we are going to need several lifetimes to absorb them. Someday we’ll look back…
Will the Support Hold?
Our indicators and charts are telling us that the market is testing its support at Dow 8,000 and S&P 500 800.
This $3 Trillion Market Is Approaching a Breaking Point
Private credit stress is building fast. Funds are limiting withdrawals – and a major reset may be coming soon.
Novavax Stock Rises as UK Covid Vax Okay Sought, Other Growth Anticipated
Novavax stock offers a unique opportunity to invest in a late stage biotech built on cutting-edge vaccine technology, NVAX stock has surged on its Covid-19…
Moderna Faces Tough Threats in the Short and Long Term
Moderna is facing meaningful short-term and longer-term threats. As a result, investors should sell MRNA stock at this point.
Novavax Stock Looks Like It’s a Solid Bet on a Coronavirus Vaccine
While it’s no guarantee that NVAX stock will be the ultimate winner from a Covid-19 vaccine, investors should pay attention to Novavax.
Without Positive Vaccine News, Novavax May Fall Further
NVAX stock is likely to stay under further pressure until it can release more positive clinical data
Merck Could Be the Covid-19 Investment You’re Missing
Some traders consider Merck stock to be a safe Dow Jones type of investment. Yet, the Covid-19 vaccine angle could propel the share price.
If You Like Alibaba Stock, these 3 ETFs Make Perfect Sense
While Alibaba stock is enticing, you may want to consider ETFs that have meaningful exposure to it. That way, if something goes wrong, your entire…
6 – 10 of 240 results
